Bioprocess Automation Software Market Size, Share & Trends Analysis Report 2025-2033 - Rising Adoption Of Digitalization and Automation In Biomanufacturing Processes

The emerging bioprocess automation software market offers opportunities in enhancing biomanufacturing efficiency and consistency through digitalization. Demand is bolstered by the need for real-time monitoring and data analytics to support quality control, aligned with Industry 4.0 and continuous bioprocessing trends.


Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Bioprocess Automation Software Market Size, Share & Trends Analysis Report by Type (Distributed Control Systems, Supervisory Control & Data Acquisition, Manufacturing Execution Systems), Application, End Use and Region with Growth Forecasts, 2025-2033" report has been added to ResearchAndMarkets.com's offering.

The global bioprocess automation software market size was estimated at USD 1.25 billion in 2024 and is projected to reach USD 3.84 billion by 2033, growing at a CAGR of 13.84% from 2025 to 2033. The industry is driven by the rising adoption of digitalization and automation in biomanufacturing, enhancing efficiency and process consistency.

Additionally, growing demand for real-time monitoring and advanced data analytics supports quality control and regulatory compliance.

Rising Adoption Of Digitalization and Automation In Biomanufacturing Processes

The rising adoption of digitalization and automation in biomanufacturing processes is a major driver of the bioprocess automation software market, as pharmaceutical and biotechnology companies increasingly seek to enhance efficiency, reduce variability, and ensure regulatory compliance. Automation software enables seamless integration of upstream and downstream operations, real-time monitoring of critical parameters, and advanced process control through platforms like MES, SCADA, and PAT.

By replacing manual, error-prone tasks with intelligent data-driven systems, manufacturers can achieve faster scale-up, improved batch consistency, and optimized resource utilization. This digital shift is also aligned with the industry's move toward continuous bioprocessing and Industry 4.0 principles, making automation software central to achieving smarter, more connected, and more agile production environments.

The need for bioprocess automation is anticipated to increase as the world's healthcare system depends more on biology for novel treatments, making it an essential part of contemporary pharmaceutical production. Automation in bioprocessing allows manufacturers to optimize production workflows, improve consistency, and increase throughput without compromising quality. Biopharmaceutical companies can produce larger biologics with reduced variability, faster turnaround times, and lower operational costs by integrating robotics, AI, and advanced monitoring systems.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Companies Featured

  • Thermo Fisher Scientific, Inc.
  • Rockwell Automation
  • Agilitech
  • Amgen
  • Andrew Alliance (Waters)
  • Synthace
  • Merck KGaA
  • Eppendorf SE
  • Bioengineering AG

Global Bioprocess Automation Software Market Report Segmentation

Type Outlook (Revenue, USD Million, 2021-2033)

  • Distributed Control Systems
  • Supervisory Control and Data Acquisition
  • Manufacturing Execution Systems
  • Laboratory Information Management Systems
  • Process Analytical Technology

Application Outlook (Revenue, USD Million, 2021-2033)

  • Upstream Processing
  • Downstream Processing
  • Quality Control
  • Manufacturing Operations
  • Data Management

End use Outlook (Revenue, USD Million, 2021-2033)

  • Pharmaceutical & biotech manufacturers
  • CDMOs & CMOs
  • Academic & research institutions
  • Contract testing & analytical labs
  • Others

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

For more information about this report visit https://www.researchandmarkets.com/r/j9nwu8

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Contact Data

Recommended Reading